Serial Number 98166766
Registration 7422075
700

Registration Progress

Application Filed
Sep 6, 2023
Under Examination
Approved for Publication
Apr 2, 2024
Published for Opposition
Apr 2, 2024
Registered
Jun 18, 2024

Trademark Image

Basic Information

Serial Number
98166766
Registration Number
7422075
Filing Date
September 6, 2023
Registration Date
June 18, 2024
Published for Opposition
April 2, 2024
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 18, 2024
Registration
Registered
Classes
005

Rights Holder

Nogra Pharma Limited

99
Address
33 Sir John Rogerson's Quay
Dublin 2 D02XK09
IE

Ownership History

Nogra Pharma Limited

Original Applicant
99
Dublin 2 IE

Nogra Pharma Limited

Owner at Publication
99
Dublin 2 IE

Nogra Pharma Limited

Original Registrant
99
Dublin 2 IE

Legal Representation

Attorney
Amy C. Ziegler

USPTO Deadlines

Next Deadline
1781 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-06-18)
Due Date
June 18, 2030
Grace Period Ends
December 18, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

24 events
Date Code Type Description Documents
Sep 24, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 24, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 24, 2024 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Sep 24, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 18, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 18, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 2, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 2, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 13, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 22, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 22, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 22, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 22, 2024 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Feb 22, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 20, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 20, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 20, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 30, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 30, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 30, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 30, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 29, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 28, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 9, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of immune system related diseases and disorders and inflammatory disorders, gastrointestinal diseases and disorders and skin disorders

Additional Information

Design Mark
The mark consists of two overlapping ovals linked together at 90 degree angles. Four curved lines come together to form each oval. The entire mark is in the color light blue. The color white represents background, outlining, shading, and/or transparent area and is not part of the mark.
Color Claim
The color(s) light blue is/are claimed as a feature of the mark.

Classification

International Classes
005